title: Which treatment for high-risk patients with DLBCL?
authors.affiliation: Hospices Civils de Lyon: Centre Hospitalier Lyon-Sud, chemin du grand Revoyet, 69310 Pierre-Bénite, France. bertrand.coiffier@univ-lyon1.fr
authors.forename: Bertrand
authors.initials: B
authors.lastname: Coiffier
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008297:Male; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab